Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-005575

EVP, COO, HEAD OF COMMERCIAL sold 624 shares at $24.67 ($15,394)

  • EVP, COO, HEAD OF COMMERCIAL acquired 1,107 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Teehan Brendan EVP, COO, HEAD OF COMMERCIAL 2024-02-23 Option exercise +1,107 32,056 D
Teehan Brendan EVP, COO, HEAD OF COMMERCIAL 2024-02-26 Sale −624 $24.67 $15,394 31,432 D
Derivatives
Teehan Brendan EVP, COO, HEAD OF COMMERCIAL 2024-02-23 Option exercise · Restricted Stock Units −1,107 1,107 D
Open-market sales · 624 sh · avg $24.67 · $15,394
Loading xslF345X05/form4-02272024_110225.xml…